Safe Use of Sodium Dodecyl Sulfate (SDS) to Deactivate SARS-CoV-2: An Evidence-Based Systematic Review

Background: Coronavirus disease (COVID-19) has now morphed into the most serious healthcare challenge that the world has faced in a century. The coronavirus disease (COVID-19) was declared as a public health emergency of international concern (PHEIC) on January 30, 2020, and a pandemic on March 11 by the World Health Organization (WHO). The number of cases and the death toll are rapidly increasing frequently because of its fast transmission from human to human through droplets, contaminated hands or body, and inanimate surfaces. Objective(s): SDS has been found to exhibit broad-spectrum and effective microbicidal and viral inactivation agents through the denaturation of both envelope and non-envelop proteins Methods: Viable SARS-COV-2 particles may also be found on contaminated sites such as steel surfaces, plastic surfaces, stainless steel, cardboard, and glass surfaces that can serve as a source of virus transmission. We reviewed the available literature about the SARS-CoV-2 persistence on inanimate surfaces as well as the decontamination strategies of corona and other viruses by using Sodium dodecyl sulfate (SDS) as well as other cleaning chemicals and disinfectants. Result(s): The efficacy of SDS has been amply demonstrated in several studies involving human immunodeficiency virus (HIV), human papillomavirus (HPV) and herpes simplex virus (HSV). SDS has also been found as deactivator of SARS-CoV-2. In toxic profile, up to 1% concentration of SDS is safe for humans and showed no toxic effect if ingested. Conclusion(s): Since no specific treatment is available as yet so containment and prevention continue to be important strategies against COVID-19. In this context, SDS can be an effective chemical disinfectant to slow and stop the further transmissions and spread of COVID-19.Copyright © 2021 Bentham Science Publishers.

Ethanol Susceptibility of SARS-CoV-2 and Other Enveloped Viruses.

Ethanol is an effective disinfectant against the novel coronavirus SARS-CoV-2. However, its effective concentration has not been shown, and we therefore analyzed the effects of different concentrations of ethanol on SARS-CoV-2. When SARS-CoV-2 was treated with varying ethanol concentrations and examined for changes in infectivity, the ethanol concentration at which 99% of the infectious titers were reduced was 24.1% (w/w) [29.3% (v/v)]. For reference, ethanol susceptibility was also examined with other envelope viruses, including influenza virus, vesicular stomatitis virus in the family Rhabdoviridae, and Newcastle disease virus in the family Paramyxoviridae, and the 99% inhibitory concentrations were found to be 28.8%(w/w) [34.8% (v/v)], 24.0% (w/w) [29.2% (v/v)], and 13.3% (w/w) [16.4% (v/v)], respectively. Some differences from SARS-CoV-2 were observed, but the differences were not significant. It was concluded that ethanol at a concentration of 30%(w/w) [36.2% (v/v)] almost completely inactivates SARS-CoV-2.

Saxifraga spinulosa-Derived Components Rapidly Inactivate Multiple Viruses Including SARS-CoV-2.

Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza A virus (IAV), and norovirus (NV) are highly contagious pathogens that threaten human health. Here we focused on the antiviral potential of the medicinal herb, Saxifraga spinulosa (SS). Water-soluble extracts of SS were prepared, and their virus-inactivating activity was evaluated against the human virus pathogens SARS-CoV-2 and IAV; we also examined virucidal activity against feline calicivirus and murine norovirus, which are surrogates for human NV. Among our findings, we found that SS-derived gallocatechin gallate compounds were capable of inactivating all viruses tested. Interestingly, a pyrogallol-enriched fraction (Fr 1C) inactivated all viruses more rapidly and effectively than did any of the component compounds used alone. We found that 25 µg/mL of Fr 1C inactivated >99.6% of SARS-CoV-2 within 10 s (reduction of ≥2.33 log10 TCID50/mL). Fr 1C resulted in the disruption of viral genomes and proteins as determined by gel electrophoresis, electron microscopy, and reverse transcription-PCR. Taken together, our results reveal the potential of Fr 1C for development as a novel antiviral disinfectant.